The shift comes after a federal court struck down sweeping changes to the pediatric vaccine schedule that went into effect in 2026. The committee of medical experts, which advises on policy at the Centers for Disease Control and Prevention (CDC), will have to focus on a cost-benefit analysis in its future analyses.

If the budget makes it through Congress intact as submitted—a big if even with the president’s party in the majority in both chambers—healthcare is in for some strict belt-tightening. 

An exclusive interview with Scott Steiner, CEO of Phoebe Putney—a nonprofit health system that serves Southwest Georgia. 

Women who underwent mammograms at the facility during the specified timeframe may need to have those exams repeated. 

The American Medical Group Association explains why it has issues with the payment adjustment for Medicare Advantage plans, arguing it fails to keep pace with the real-world costs.

The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.

Radiopharma firm Telix hopes to soon begin selling Pixclara (Floretyrosine F 18), an investigational product for glioma, a type of brain cancer. 

The coalition of plaintiffs—representing 19 states and Washington, D.C.—is challenging many of the changes made by Elon Musk’s Department of Government Efficiency, which has since halted operations. State governments argue that HHS is no longer performing its constitutionally required duties. The agency’s attempt to dismiss the lawsuit was rejected this week.